Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

This study has been terminated.

(Unable to enroll breast cancer patients with current I/E criteria.)

Sponsor:

Information provided by (Responsible Party):

Siemens Molecular Imaging

ClinicalTrials.gov Identifier:

NCT01362712

First received: May 13, 2011

Last updated: May 17, 2012

Last verified: May 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2012
Primary Completion Date:	January 2012 (Final data collection date for primary outcome measure)